Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China
· Delayed Price · Currency is CNY 6.58
-0.73 (-9.99%)
Apr 29, 2026, 3:04 PM CST
SHE:002099 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 10,415 | 9,877 | 8,190 | 11,639 | 11,347 | 13,338 | Upgrade
|
| Market Cap Growth | 25.22% | 20.59% | -29.63% | 2.57% | -14.93% | -3.06% | Upgrade
|
| Enterprise Value | 10,644 | 9,669 | 7,823 | 11,071 | 10,844 | 11,966 | Upgrade
|
| Last Close Price | 6.58 | 6.24 | 5.16 | 7.19 | 6.97 | 8.07 | Upgrade
|
| PE Ratio | - | - | - | - | 128.93 | 140.06 | Upgrade
|
| Forward PE | - | 15.91 | 15.91 | 15.91 | 15.91 | 15.91 | Upgrade
|
| PS Ratio | 5.60 | 5.31 | 4.22 | 5.36 | 4.20 | 5.37 | Upgrade
|
| PB Ratio | 2.11 | 1.96 | 1.60 | 2.08 | 1.86 | 2.18 | Upgrade
|
| P/TBV Ratio | 2.57 | 2.38 | 1.94 | 2.60 | 2.34 | 2.74 | Upgrade
|
| P/FCF Ratio | - | - | 155.34 | 133.07 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 46.85 | 48.39 | 97.74 | 130.31 | Upgrade
|
| EV/Sales Ratio | 5.72 | 5.20 | 4.04 | 5.10 | 4.01 | 4.82 | Upgrade
|
| EV/EBITDA Ratio | 31.02 | 29.76 | 37.89 | 119.42 | 25.23 | 29.45 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 110.50 | 102.12 | Upgrade
|
| EV/FCF Ratio | -69.40 | - | 148.38 | 126.58 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.26 | 0.24 | 0.19 | 0.16 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 3.19 | 3.76 | 5.85 | 10.86 | 2.30 | 1.44 | Upgrade
|
| Debt / FCF Ratio | - | - | 23.40 | 12.06 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.05 | -0.02 | -0.06 | -0.06 | -0.08 | -0.20 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.73 | -0.32 | -1.59 | -3.94 | -1.14 | -3.06 | Upgrade
|
| Net Debt / FCF Ratio | -1.55 | 0.78 | -6.23 | -4.18 | 7.72 | 9.78 | Upgrade
|
| Asset Turnover | 0.25 | 0.25 | 0.26 | 0.27 | 0.33 | 0.33 | Upgrade
|
| Inventory Turnover | 1.57 | 1.65 | 2.12 | 2.20 | 2.01 | 1.96 | Upgrade
|
| Quick Ratio | 0.68 | 0.84 | 0.91 | 1.04 | 1.05 | 1.39 | Upgrade
|
| Current Ratio | 1.20 | 1.28 | 1.30 | 1.45 | 1.65 | 1.98 | Upgrade
|
| Return on Equity (ROE) | -1.50% | -1.85% | -6.22% | -7.20% | 1.41% | 1.57% | Upgrade
|
| Return on Assets (ROA) | -0.09% | -0.10% | -1.10% | -2.10% | 0.75% | 0.96% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.21% | -0.23% | -2.62% | -4.93% | 1.60% | 1.95% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.20% | -0.20% | -2.50% | -4.70% | 1.50% | 1.90% | Upgrade
|
| Earnings Yield | -0.71% | -0.92% | -4.03% | -3.61% | 0.78% | 0.71% | Upgrade
|
| FCF Yield | -1.47% | -1.36% | 0.64% | 0.75% | -0.56% | -0.95% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.72% | 1.24% | Upgrade
|
| Payout Ratio | - | - | - | - | 222.06% | 56.13% | Upgrade
|
| Buyback Yield / Dilution | -15.88% | 3.48% | 2.66% | 8.22% | -10.91% | 0.71% | Upgrade
|
| Total Shareholder Return | -15.88% | 3.48% | 2.66% | 8.22% | -10.19% | 1.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.